BIOSANTE PHARMACEUTICALS INC 4
4 · BIOSANTE PHARMACEUTICALS INC · Filed Jul 16, 2013
Insider Transaction Report
Form 4
Penn Thomas A.
Director10% Owner
Transactions
- Award
Option to Purchase
2013-07-12+20,000→ 20,000 totalExercise: $1.06Exp: 2023-07-11→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]Option vests over a four year period beginning on the first anniversary of the grant date.